Viridian Therapeutics Inc.

06/03/2026 | Press release | Distributed by Public on 06/03/2026 05:00

Proxy Results (Form 8-K)

Item 5.07

Submission of Matters to a Vote of Security Holders.

On June 2, 2026, Viridian Therapeutics, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting") at which holders of the Company's common stock as of the close of business on April 7, 2026 (the "Record Date") were entitled to vote. As of the close of business on the Record Date, 103,071,889 shares of the Company's common stock were issued and outstanding.

At the Annual Meeting, each of the Company's director nominees was elected and the other proposals voted on were approved. The final voting results are set forth below:

1. Election of the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders:

For Withheld Broker Non-Votes

Tomas Kiselak

72,363,500 14,475,646 6,733,104

Jennifer K. Moses

86,378,842 460,304 6,733,104

2. Ratification of the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026:

For

Against

Abstentions

Broker Non-Votes

92,866,008 512,582 193,660 -

3. Approval, on an advisory basis, of the compensation of the Company's named executive officers:

For

Against

Abstentions

Broker Non-Votes

83,512,086 3,113,724 213,336 6,733,104

4. Approval, on an advisory basis, of the frequency of holding an advisory vote on the compensation of the Company's named executive officers:

1 Year

2 Years

3 Years

Abstain

86,084,347 29,762 517,682 207,355

As a result of the foregoing vote, the Company's Board of Directors has determined that the Company will conduct a non-binding advisory vote on the compensation of the Company's named executive officers every year.

Viridian Therapeutics Inc. published this content on June 03, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 03, 2026 at 11:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]